Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial

BACKGROUND: Low-dose dexamethasone demonstrated clinical improvement in patients with coronavirus disease 2019 (COVID-19) needing oxygen therapy; however, evidence on the efficacy of high-dose dexamethasone is limited. METHODS: We performed a randomised, open-label, controlled trial involving hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Taboada, Manuel, Rodríguez, Nuria, Varela, Pablo Manuel, Rodríguez, María Teresa, Abelleira, Romina, González, Amara, Casal, Ana, Díaz Peromingo, José Antonio, Lama, Adriana, Domínguez, María Jesús, Rábade, Carlos, Páez, Emilio Manuel, Riveiro, Vanessa, Pernas, Hadrián, Beceiro, María del Carmen, Caruezo, Valentín, Naveira, Alberto, Cariñena, Agustín, Cabaleiro, Teresa, Estany-Gestal, Ana, Zarra, Irene, Pose, Antonio, Valdés, Luis, Álvarez-Escudero, Julián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678498/
https://www.ncbi.nlm.nih.gov/pubmed/34916266
http://dx.doi.org/10.1183/13993003.02518-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678498/
https://www.ncbi.nlm.nih.gov/pubmed/34916266
http://dx.doi.org/10.1183/13993003.02518-2021

Ejemplares similares